>fields of developmental biology and/or neurologic animal models such as >Opportunities are available for innovative scientists who are experienced in Experience with neurological models preferred. >years of experience working with animal behavioral testing, cell cultures, >Animal Testing/ Cell transplantation Specialist: B.S. >Molecular Biology Specialist: BS/MS, 3+years experienc with viral >molecular biology, immunohistochemistry. >Cell Culture Specialist: BS/MS, 3+ years experience with cell cultures, >new facility based on FACs-adavantage SE. >FAC Sorting Specialist: BS/MS, 3+ years experience. >energetic, innovative Scientists, Research Associates, to join our >cell technologies to treat various neurological diseases. >Neuronyx is a young biotechnology company concentrating on utilizing stem In reply to: Tony Ho: "Neuronyx: FAC operator position available".Previous message: Michele Lutz: "Research Operator needed".Next message: Witherspoon, Sam: "Correction RE: Monoclonal Schneider S2 cells".The technology has the capability to accelerate the process of identifying and selecting antibodies for target antigens, reducing the cost and development time by up to 50% of the current process.ApoLife uses its technology to develop anticancer antibodies and immunotoxins with collaborating partners.As a licensing partner, ApoLife has vectors, yeast strains, and production process available for antibody and biogeneric product development.Purdue Cytometry Mailing List: Re: Neuronyx: FAC operator posit Re: Neuronyx: FAC operator position available From: Fatima Abbasi Latif ( Mon 12:59:52 EST ApoLife's platform has the capability to make fully functional secreted antibodies and has potential to improve antibody potency. ApoLife employs Bakers yeast (S.cerevisiae) which has been used for manufacturing several FDA approved therapeutic products thus giving ApoLife a competitive regulatory advantage over companies using other yeast systems. viral vaccines).ĪpoLife has developed platform yeast expression technologies for accelerated development of therapeutic antibodies (glycosylated and aglycosylated), antibody fragments, fusion proteins and antibodies and subunit vaccines through its Twin Cassette yeast system. As a consequence, however, Grand River APP cannot process cytotoxic/genotoxic or virally-based candidates (e.g.
Typical products envisioned for Grand River APP services include small molecule drugs, peptides, monoclonal antibodies, therapeutic proteins and nano-medicines. This process, Fill/Finish and Lyophilization, will be offered broadly to academic, nonprofit, and for-profit organizations in Michigan and across North America for liquid-based drug candidates that require vialing in an FDA-regulated aseptic clean room environment.
Grand River APP's first aims to assure that therapeutics are properly distributed into dosage forms for all-important Phase I and Phase II human clinical trials. Grand River APP is the result of an alliance between Van Andel Institute (and Grand Valley State University, and is operating as a non-profit, state- and federally funded corporation. Grand River Aseptic Pharmaceutical Packaging is a pharmaceutical contract manufacturing organization (CMO) supporting the rapid development of new biomedicines to the clinical stage in the State of Michigan.
0 kommentar(er)
